Back to Search
Start Over
Ebola: should we consider influenza vaccination?
- Source :
- The Lancet, The Lancet, 2014, 384 (9959), pp.2023-2024. ⟨10.1016/S0140-6736(14)62226-1⟩, The Lancet, Elsevier, 2014, 384 (9959), pp.2023-2024. ⟨10.1016/S0140-6736(14)62226-1⟩
- Publication Year :
- 2014
- Publisher :
- HAL CCSD, 2014.
-
Abstract
- International audience
- Subjects :
- Adult
Diagnosis, Differential
MESH: Influenza Vaccines
03 medical and health sciences
0302 clinical medicine
MESH: Diagnosis, Differential
Influenza, Human
Medicine
Humans
030212 general & internal medicine
MESH: Travel
ComputingMilieux_MISCELLANEOUS
030304 developmental biology
0303 health sciences
Travel
MESH: Guinea
MESH: Humans
business.industry
MESH: Influenza, Human
Vaccination
MESH: Adult
General Medicine
MESH: Vaccination
Hemorrhagic Fever, Ebola
Virology
Influenza Vaccines
MESH: Hemorrhagic Fever, Ebola
[SDV.MP.VIR]Life Sciences [q-bio]/Microbiology and Parasitology/Virology
Female
Guinea
business
MESH: Female
Subjects
Details
- Language :
- English
- ISSN :
- 01406736, 1474547X, and 09237577
- Database :
- OpenAIRE
- Journal :
- The Lancet, The Lancet, 2014, 384 (9959), pp.2023-2024. ⟨10.1016/S0140-6736(14)62226-1⟩, The Lancet, Elsevier, 2014, 384 (9959), pp.2023-2024. ⟨10.1016/S0140-6736(14)62226-1⟩
- Accession number :
- edsair.doi.dedup.....49009be479b1886c6b5d7b2573f828ac
- Full Text :
- https://doi.org/10.1016/S0140-6736(14)62226-1⟩